Regulatory shifts and payer actions are reshaping how patients access therapy. Recent policy and market developments are increasing coverage complexity, driving more patients to patient assistance ...
On this Ropes & Gray podcast, health care partner Michael Lampert and counsel Sam Perrone, and litigation & enforcement partner Andrew O’Connor, rejoin to discuss patient assistance programs, recent ...
Copayment accumulators and maximizers have the potential to harm patients’ access to necessary medicines. Health care payers (including employers, insurers, and pharmacy benefit managers), regulators, ...
Co-pay accumulators and maximizers are 2 programs that insurers have started implementing to help them redirect financial assistance from the patient, said Kimberly Westrich, MA, chief strategy ...
When Gury Doshi, MD, learned that a patient’s insurance didn’t cover her breast cancer medication, Doshi had a potential workaround. The patient could try to bypass the insurer and access the drug at ...
Associations of Financial Hardship and Health Status, Social Functioning, and Mental Health Among Cancer Survivors in the United States: Findings From a Nationally Representative Study Ulman ...
The emergence of Lilly’s bundling strategy for Zepbound and Taltz reflects the unregulated state of patient assistance programs in the commercial market and the need for Congressional intervention. A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results